0000000000898543

AUTHOR

Pertti Karppi

showing 2 related works from this author

Effect of cognitive impairment on basic activities of daily living in hip fracture patients: a 1-year follow-up.

2007

Background and aims: To compare changes in basic self-care activities in various cognitive groups of hip fracture patients by the Katz Index of Independence in activities of daily living (ADL). Methods: 117 community-dwelling elderly subjects with acute hip fracture (age 67–92 years), referred to the geriatric unit of Jyvaskyla Central Hospital for rehabilitation, participated in the study. Basic self-care activities were evaluated by the Katz ADL Index and cognition by the Mini-Mental State Examination (MMSE). Results: Prior to hip fracture, the patients in the lowest MMSE group had a significantly lower Katz Index than the other three groups (p<0.001). Disability increased in a statistica…

MaleAgingmedicine.medical_specialtyActivities of daily livingmedicine.medical_treatment1 year follow upActivities of Daily LivingMedicineHumansFunctional abilityKatz indexCognitive impairmentAgedAged 80 and overHip fractureRehabilitationbusiness.industryGeriatrics gerontologyHip Fracturesmedicine.diseasePhysical therapyFemaleGeriatrics and GerontologybusinessCognition Disordershuman activitiesFollow-Up StudiesAging clinical and experimental research
researchProduct

Randomized, Double-Blind, Clinically Controlled Trial of Intranasal Calcitonin Treatment in Patients with Hip Fracture

2002

The objective of this study was to evaluate the short-term outcome of intranasal calcitonin treatment of elderly hip fracture patients on pain, bone loss, functional recovery, and length of hospital stay. In addition, we wanted to compare the effect of calcitonin with placebo on fusion of hip fractures treated with internal fixation using a screw or a nail. In a randomized, double-blind, clinically controlled trial, 260 independently living patients (aged 65 years or older) with acute hip fracture were randomly assigned to intranasal calcitonin 200 IU daily for 3 months or matching placebo nasal spray. Analyses were completed on an intention-to-treat basis. Three months after the operation,…

CalcitoninMalemedicine.medical_specialtyVisual analogue scaleEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisPainPlacebolaw.inventionFracture Fixation InternalEndocrinologyDouble-Blind MethodRandomized controlled trialBone DensitylawActivities of Daily LivingFracture fixationmedicineHumansInternal fixationOrthopedics and Sports MedicineBone ResorptionAdministration IntranasalOsteoporosis PostmenopausalAgedPain MeasurementAged 80 and overFracture HealingHip fractureHip Fracturesbusiness.industryLength of Staymedicine.diseaseSurgeryCalcitoninFemalebusinessCalcified Tissue International
researchProduct